Gradient Investments’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Gradient Investments’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-13	Closed	-$2K	–	636
2024 Q2	$2K	Buy	+13	New	+$1.95K	﹤0.01%	986
2024 Q1	–	Sell	-150	Closed	-$23.7K	–	1424
2023 Q4	$23.7K	Sell	150 -100	-40%	-$14.4K	﹤0.01%	673
2023 Q3	$36.6K	Hold	250	–	–	﹤0.01%	569
2023 Q2	$38.3K	Sell	250 -94	-27%	-$14.7K	﹤0.01%	557
2023 Q1	$53.3K	Hold	344	–	–	﹤0.01%	487
2022 Q4	$53K	Hold	344	–	–	﹤0.01%	494
2022 Q3	$45K	Sell	344 -500	-59%	-$70.2K	﹤0.01%	496
2022 Q2	$114K	Hold	844	–	–	﹤0.01%	360
2022 Q1	$126K	Hold	844	–	–	﹤0.01%	343
2021 Q4	$137K	Hold	844	–	–	﹤0.01%	320
2021 Q3	$140K	Sell	844 -28	-3%	-$4.78K	﹤0.01%	324
2021 Q2	$151K	Hold	872	–	–	﹤0.01%	316
2021 Q1	$140K	Hold	872	–	–	﹤0.01%	321
2020 Q4	$137K	Hold	872	–	–	0.01%	285
2020 Q3	$137K	Hold	872	–	–	0.01%	285
2020 Q2	$146K	Buy	872 +694	+390%	+$109K	0.01%	263
2020 Q1	$23K	Hold	178	–	–	﹤0.01%	484
2019 Q4	$26K	Buy	178 +28	+19%	+$3.85K	﹤0.01%	524
2019 Q3	$19K	Hold	150	–	–	﹤0.01%	531
2019 Q2	$21K	Hold	150	–	–	﹤0.01%	505
2019 Q1	$23K	Hold	150	–	–	﹤0.01%	427
2018 Q4	$19K	Hold	150	–	–	﹤0.01%	458
2018 Q3	$24K	Hold	150	–	–	﹤0.01%	464
2018 Q2	$21K	Hold	150	–	–	﹤0.01%	476
2018 Q1	$20K	Hold	150	–	–	﹤0.01%	472
2017 Q4	$19K	Buy	+150	New	+$18.5K	﹤0.01%	479
2017 Q3	–	Sell	-150	Closed	-$17K	–	384
2017 Q2	$17K	Buy	+150	New	+$16.1K	﹤0.01%	408
2013 Q3	–	Sell	-19	Closed	-$1K	–	519
2013 Q2	$1K	Buy	+19	New	+$1.08K	﹤0.01%	400

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Gradient Investments's FBT Position: Q3 2024 in Review

Gradient Investments sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2024, closing a stake of 13 shares — an estimated $2K sold.

Gradient Investments first reported a position in FBT in Q2 2013 and held it in 28 quarters. The position peaked at $151K in Q2 2021. 257 funds tracked by Wall St. Rank hold FBT as of Q3 2024.

Gradient Investments reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2024 after selling out during the quarter.
Gradient Investments sold 13 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2024, an estimated $2K.
Gradient Investments first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and held it in 28 quarters.
Gradient Investments's First Trust NYSE Arca Biotechnology Index Fund position peaked at $151K in Q2 2021.
257 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2024.

Based on Gradient Investments's 13F filing for Q3 2024, filed 15 Oct 2024.